Clinical Implications of Monogenic Versus Polygenic Hypercholesterolemia: Long‐Term Response to Treatment, Coronary Atherosclerosis Burden, and Cardiovascular Events
Background Familial hypercholesterolemia (FH) may arise from deleterious monogenic variants in FH‐causing genes as well as from a polygenic cause. We evaluated the relationships between monogenic FH and polygenic hypercholesterolemia in influencing the long‐term response to therapy and the risk of a...
Principais autores: | Laura D’Erasmo, Ilenia Minicocci, Alessia Di Costanzo, Giovanni Pigna, Daniela Commodari, Fabrizio Ceci, Anna Montali, Francesca Brancato, Ilaria Stanca, Antonio Nicolucci, Andrea Ascione, Nicola Galea, Iacopo Carbone, Marco Francone, Marianna Maranghi, Marcello Arca |
---|---|
Formato: | Artigo |
Idioma: | English |
Publicado em: |
Wiley
2021-05-01
|
coleção: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
Assuntos: | |
Acesso em linha: | https://www.ahajournals.org/doi/10.1161/JAHA.120.018932 |
Registros relacionados
-
Higher Responsiveness to Rosuvastatin in Polygenic versus Monogenic Hypercholesterolemia: A Propensity Score Analysis
por: Agnieszka Mickiewicz, et al.
Publicado em: (2020-05-01) -
Family and polygenic hypercholesterolemia: similarities and differencies by long-term follow-up
por: B M Lipovetskiy, et al.
Publicado em: (2009-03-01) -
A polygenic biomarker to identify patients with severe hypercholesterolemia of polygenic origin
por: Luis G. Leal, et al.
Publicado em: (2020-06-01) -
Polygenic risk score for hypercholesterolemia in a Brazilian familial hypercholesterolemia cohort
por: Isabella Ramos Lima, et al.
Publicado em: (2022-08-01) -
Efficacy of Evolocumab in Monogenic vs Polygenic Hypercholesterolemia
por: Timothy Lee, BSc, et al.
Publicado em: (2019-05-01)